心脾同治方治疗气虚血瘀型冠心病稳定型心绞痛临床观察

Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai(2017)

Cited 0|Views4
No score
Abstract
目的:观察心脾同治方治疗气虚血瘀型冠心病稳定型心绞痛的临床疗效.方法:选择气虚血瘀型冠心病稳定型心绞痛患者70例,随机分为对照组和治疗组,每组各35例.对照组采用西医常规疗法治疗,治疗组在对照组基础上加用心脾同治方口服治疗,两组疗程均为8周.比较两组患者的中医证候积分、中医证候疗效、心绞痛疗效及心电图疗效.结果:治疗后,两组患者的中医证候积分较治疗前均明显减少(P<0.01),且治疗组患者的积分减少程度优于对照组(P<0.01).治疗后,治疗组的中医证候疗效总有效率为91.42%,对照组为74.28%,治疗组疗效优于对照组(P<0.05);治疗组改善心绞痛疗效的总有效率为85.71%,对照组为65.71%,治疗组的疗效优于对照组(P<0.05);治疗组改善心电图疗效的总有效率为65.71%,对照组为48.57%,两组疗效比较差异无统计学意义(P>0.05).结论:心脾同治方结合西医常规疗法治疗气虚血瘀型冠心病稳定型心绞痛患者,能明显减少患者心绞痛的发作频次,改善中医证候.
More
Translated text
Key words
coronary heart disease,stable angina pectoris,qi-deficiency and blood-stasis type," Xinpi Tongzhi Decoction"
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined